5,7-Dihydroxy-3',4'-dimethoxy-8-(3-hydroxy-3-methylbutyl)-isoflavone 7-glucoside



Compound IDCDAMM00394
Common name5,7-Dihydroxy-3',4'-dimethoxy-8-(3-hydroxy-3-methylbutyl)-isoflavone 7-glucoside
IUPAC name3-(3,4-dimethoxyphenyl)-5-hydroxy-8-(3-hydroxy-3-methylbutyl)-7-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxychromen-4-one
Molecular formulaC28H34O12

Experimental data

Retention time35.87
Adduct[M+H]+
Actual mz563.209
Theoretical mz563.212
Error6.39
Ionizaton modePositive
Instrument typeLC-MS/MS-QTOF, spectrum predicted by MS-DIAL v4.9 integrated with MS-FINDER 3.60
Score5.97

Identifiers and class information

Inchi keyAQOVBCDOFOOETK-QERVRDGFNA-N
SmilesO=C1C(=COC=2C1=C(O)C=C(OC3OC(CO)C(O)C(O)C3O)C2CCC(O)(C)C)C=4C=CC(OC)=C(OC)C4
SuperclassPhenylpropanoids and polyketides
ClassIsoflavonoids

Pharmacokinetic properties

Number of descriptor values(#stars)2
Number of non-conjugated amine groups (#amine)0
Number of amidine and guanidine groups (#amidine)0
Number of carboxylic acid groups (#acid)0
Number of non-conjugated amide groups (#amide)0
Number of rotatable bonds (#rotor)15
Number of reactive functional groups (#rtvFG)1
Predicted central nervous system activity (CNS)-2
Molecular weight (mol_MW)562.569
Computed dipole moment(dipole)3.5
Total solvent accessible surface area (SASA)865.889
Hydrophobic component of SASA (FOSA)443.906
Hydrophilic component of SASA (FISA)268.751
Pie component of the SASA (PISA)153.232
Weakly polar component of the SASA (WPSA)0
Total solvent accesible volume (volume)1634.99
Number of hydrogen bond donors (donorHB)5
Number of hydrogen bond acceptors (accptHB)13.75
Free energy of solvation of dipole (dip^2/V)0.0074931
Index of cohesive interaction in solids (ACxDN^.5/SA)0.0355079
Globularity descriptor (glob)0.775138
Predicted polarizability in cubic angstroms (QPpolrz)51.11
Predicted hexadecane/gas partition coefficient (QPlogPC16)17.655
Predicted octanol/gas partition coefficient (QPlogPoct)31.987
Predicted water/gas partition coefficient (QPlogPw)22.231
Predicted octanol/water partition coefficient (QPlogPo/w)1.661
Predicted aqueous solubility (QPlogS)-4.526
Conformation-independent predicted aqueous solubility (CIQPlogS)-5.948
Predicted IC50 value for blockage of HERG K+ channels (QPlogHERG)-5.901
Predicted apparent Caco-2 cell permeability in nm/sec (QPPCaco)28.011
Predicted brain/blood partition coefficient (QPlogBB)-3.323
Predicted apparent MDCK cell permeability in nm/sec (QPPMDCK)10.378
Predicted skin permeability, log Kp (QPlogKp)-4.493
PM3 calculated ionization potential (IP(ev))8.564
PM3 calculated electron affinity (EA(eV))0.608
Number of likely metabolic reactions (#metab)9
Prediction of binding to human serum albumin (QPlogKhsa)-0.334
Predicted qualitative human oral absorption (HumanOralAbsorption)2
Predicted human oral absorption on 0 to 100% scale (PercentHumanOralAbsorption)23.697
Solvent-accessible surface area of fluorine atoms (SAFluorine)0
Solvent-accessible surface area of amide oxygen atoms (SAamideO)0
Van der Waals surface area (PSA)186.633
Number of nitrogen and oxygen atoms (#NandO)12
Number of violations of Lipinski’s rule of five (RuleOfFive)3
Number of violations of Jorgensen’s rule of three (RuleOfThree)1

Compound-target network

Cytoscape Graph

Protein targets associated with phytocompound

Uniprot ID Gene name Target name TTD_ID Prediction source
P43166CA7Carbonic anhydrase VIIT37541SEA
O43868SLC28A2Sodium/nucleoside cotransporter 2T94627SEA
P01112HRASTransforming protein p21/H-Ras-1T71081SEA
P60568IL2Interleukin-2T61698SEA
Q9NUW8TDP1Tyrosyl-DNA phosphodiesterase 1T33492SEA
P14679TYRTyrosinaseT97035SEA
Q9GZQ4NMUR2Neuromedin-U receptor 2T04210SEA
P16152CBR1Carbonyl reductase [NADPH] 1T70518SEA
Q9NZ08ERAP1Endoplasmic reticulum aminopeptidase 1T72849SEA
P05231IL6Interleukin-6T32578SEA
P30837ALDH1B1Acetaldehyde dehydrogenaseT99641SEA

Target associated diseases

TTD_ID Disease_ID Disease name ICD_11 Uniprot ID Gene names
T61698DI0275Multiple sclerosis[ICD-11: 8A40]P60568IL2
T61698DI0361Renal cell carcinoma[ICD-11: 2C90]P60568IL2
T97035DI0007Acquired hypermelanosis[ICD-11: ED60]P14679TYR
T97035DI0008Acquired hypomelanotic disorder[ICD-11: ED63]P14679TYR
T70518DI0037Asthma[ICD-11: CA23]P16152CBR1
T32578DI0028Anemia[ICD-11: 3A00-3A9Z]P05231IL6
T99641DI0396Substance abuse[ICD-11: 6C40]P30837ALDH1B1

Copyright © 2025